Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0001 USD | 0.00% | 0.00% | +9,900.00% |
2022 | Kaleido Biosciences, Inc.(NasdaqGS:KLDO) dropped from S&P Global BMI Index | CI |
2022 | Kaleido Biosciences, Inc.(NasdaqGS:KLDO) dropped from S&P TMI Index | CI |
Financials (USD)
Sales 2020 | 0.98 | Sales 2021 | 1.1 | Capitalization | 102M |
---|---|---|---|---|---|
Net income 2020 | -81M | Net income 2021 | -90M | EV / Sales 2020 | 309,973,492 x |
Net cash position 2020 | 25.21M | Net cash position 2021 | 16.78M | EV / Sales 2021 | 77,011,319 x |
P/E ratio 2020 |
-3.73
x | P/E ratio 2021 |
-1.11
x | Employees | 76 |
Yield 2020 * |
-
| Yield 2021 |
-
| Free-Float | 100% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Tech/Sci/R&D Officer | - | 19-10-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Chairman | 64 | 19-07-10 | |
Jean K. Mixer
BRD | Director/Board Member | 57 | 19-09-29 |
Anthony Quinn
BRD | Director/Board Member | 62 | 16-01-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-20 | 0.0001 | 0.00% | 1,863 |
24-05-15 | 0.0001 | 0.00% | 6,333 |
24-05-14 | 0.0001 | 0.00% | 309 |
Delayed Quote OTC Markets, May 20, 2024 at 02:36 pm EDT
More quotesAnnual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+9,900.00% | 4.26K | |
+41.79% | 50.93B | |
-0.56% | 42.12B | |
+49.62% | 42.05B | |
-7.20% | 29.18B | |
+12.59% | 26.02B | |
-21.51% | 18.9B | |
+6.92% | 13.21B | |
+24.91% | 12.17B | |
+29.60% | 12.16B |
- Stock Market
- Equities
- KLDO Stock